COEs are emerging antimicrobials to combat drug resistant infections and to which bacteria develop only limited resistance.
No takes yet. Share an insight, caveat, or question.
Chilambi et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: